M. Davies and A. Thomas, Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina., Heart, vol.53, issue.4, pp.363-73, 1985.
DOI : 10.1136/hrt.53.4.363

V. Fuster, P. Moreno, Z. Fayad, R. Corti, and J. Badimon, Atherothrombosis and High-Risk Plaque, Journal of the American College of Cardiology, vol.46, issue.6, pp.937-54, 2005.
DOI : 10.1016/j.jacc.2005.03.074

URL : http://doi.org/10.1016/j.jacc.2005.03.074

J. Cheng, H. Garcia-garcia, S. De-boer, I. Kardys, J. Heo et al., In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study, European Heart Journal, vol.35, issue.10, pp.639-686, 2014.
DOI : 10.1093/eurheartj/eht484

S. Rittersma, A. Van-der-wal, K. Koch, J. Piek, J. Henriques et al., Plaque Instability Frequently Occurs Days or Weeks Before Occlusive Coronary Thrombosis: A Pathological Thrombectomy Study in Primary Percutaneous Coronary Intervention, Circulation, vol.111, issue.9, pp.1160-1165, 2005.
DOI : 10.1161/01.CIR.0000157141.00778.AC

E. Steg, P. James, S. Atar, D. Badano, L. Blömstrom-lundqvist et al., Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J. oct, vol.33, issue.20, pp.2569-619, 2012.

M. Davies, CORONARY DISEASE: The pathophysiology of acute coronary syndromes, Heart, vol.83, issue.3, pp.361-367, 2000.
DOI : 10.1136/heart.83.3.361

S. Savonitto, D. Ardissino, C. Granger, G. Morando, M. Prando et al., Prognostic Value of the Admission Electrocardiogram in Acute Coronary Syndromes, JAMA, vol.281, issue.8, pp.707-720, 1999.
DOI : 10.1001/jama.281.8.707

J. Volmink, J. Newton, N. Hicks, P. Sleight, G. Fowler et al., Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group, Heart Br Card Soc. juill, vol.80, issue.1, pp.40-44, 1998.

L. Mandelzweig, A. Battler, V. Boyko, H. Bueno, N. Danchin et al., The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004, European Heart Journal, vol.27, issue.19, pp.2285-93, 2004.
DOI : 10.1093/eurheartj/ehl196

J. Alpert, K. Thygesen, E. Antman, and J. Bassand, Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction, J Am Coll Cardiol. sept, vol.36, issue.3, pp.959-69, 2000.

J. Bassand, C. Hamm, D. Ardissino, E. Boersma, A. Budaj et al., Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes], Rev Port Cardiol Orgão Of Soc Port Cardiol Port J Cardiol Off J Port Soc Cardiol. sept, vol.27, issue.9, pp.1063-143, 2008.

A. Goch, P. Misiewicz, J. Rysz, and M. Banach, The Clinical Manifestation of Myocardial Infarction in Elderly Patients, Clinical Cardiology, vol.55, issue.6, pp.46-51, 2009.
DOI : 10.1002/clc.20354

E. Omerovic, G. Brohall, M. Müller, T. Råmunddal, G. Matejka et al., Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria, Therapeutics and Clinical Risk Management, vol.4, issue.4, pp.705-717, 2008.
DOI : 10.2147/TCRM.S2826

K. Thygesen, J. Alpert, H. White, E. Joint, and . Aha, WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction, Eur Heart J. oct, vol.28, issue.20, pp.2525-2563, 2007.

B. Mccarthy, J. Wong, and H. Selker, Detecting acute cardiac ischemia in the emergency department, Journal of General Internal Medicine, vol.87, issue.3, pp.365-73, 1990.
DOI : 10.1007/BF02600409

G. Rouan, T. Lee, E. Cook, D. Brand, M. Weisberg et al., Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms (a report from the Multicenter Chest Pain Study), The American Journal of Cardiology, vol.64, issue.18, pp.1087-92, 1989.
DOI : 10.1016/0002-9149(89)90857-6

F. Apple, H. Quist, and M. Murakami, Diagnostic and prognostic value of cardiac troponin I assays in patients admitted with symptoms suggestive of acute coronary syndrome, Arch Pathol Lab Med. avr, vol.128, issue.4, pp.430-434, 2004.

S. Achar, S. Kundu, and W. Norcross, Diagnosis of acute coronary syndrome, Am Fam Physician. 1 juill, vol.72, issue.1, pp.119-145, 2005.

G. Luca, H. Suryapranata, J. Ottervanger, and E. Antman, Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts, Circulation, vol.109, issue.10, pp.1223-1228, 2004.
DOI : 10.1161/01.CIR.0000121424.76486.20

J. Cambou, N. Danchin, Y. Boutalbi, G. Hanania, R. Humbert et al., Evolution of the management and outcomes of patients admitted for acute myocardial infarction in France from 1995 to 2000: data from the USIK 1995 and USIC 2000 nationwide registries], Ann Cardiol Angéiologie. janv, vol.53, issue.1, pp.12-19, 2004.

N. Danchin, P. Coste, J. Ferrières, P. Steg, Y. Cottin et al., Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI), Circulation, vol.118, issue.3, pp.268-76, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.762765

E. Puymirat, T. Simon, P. Steg, F. Schiele, P. Guéret et al., Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, JAMA, vol.308, issue.10, pp.998-1006, 2012.
DOI : 10.1001/2012.jama.11348

R. Luepker, J. Raczynski, S. Osganian, R. Goldberg, J. Finnegan et al., Effect of a Community Intervention on Patient Delay and Emergency Medical Service Use in Acute Coronary Heart Disease, JAMA, vol.284, issue.1, pp.60-67, 2000.
DOI : 10.1001/jama.284.1.60

C. Terkelsen, J. Sørensen, M. Maeng, L. Jensen, H. Tilsted et al., System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention, JAMA, vol.304, issue.7
DOI : 10.1001/jama.2010.1139

M. Sabatine, D. Morrow, G. Montalescot, M. Dellborg, J. Leiva-pons et al., Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 Trial, Circulation, vol.112, issue.25
DOI : 10.1161/CIRCULATIONAHA.105.595397

P. Théroux, D. Waters, S. Qiu, J. Mccans, P. De-guise et al., Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina, Circulation, vol.88, issue.5, pp.2045-2053, 1993.
DOI : 10.1161/01.CIR.88.5.2045

C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight et al., ISIS-2: 10??year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither, The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. BMJ. 2 mai, pp.1337-1380, 1998.
DOI : 10.1136/bmj.316.7141.1337

P. Barragan, P. Pietri, P. Villain, M. Silvestri, and P. Roquebert, Antiplatelet therapy during coronary endoprosthesis placement]. Arch Mal Coeur Vaiss, nov, vol.89, issue.11, pp.1515-1535, 1996.

S. Yusuf, F. Zhao, S. Mehta, S. Chrolavicius, G. Tognoni et al., Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med. 16 août, vol.345, issue.7, pp.494-502, 2001.

S. Mehta, S. Yusuf, R. Peters, M. Bertrand, B. Lewis et al., Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, The Lancet, vol.358, issue.9281, pp.527-560, 2001.
DOI : 10.1016/S0140-6736(01)05701-4

S. Mehta, J. Tanguay, J. Eikelboom, S. Jolly, C. Joyner et al., Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial, The Lancet, vol.376, issue.9748, pp.1233-1276, 2010.
DOI : 10.1016/S0140-6736(10)61088-4

J. Snoep, M. Hovens, J. Eikenboom, J. Van-der-bom, J. Jukema et al., Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis, American Heart Journal, vol.154, issue.2, pp.221-252, 2007.
DOI : 10.1016/j.ahj.2007.04.014

V. Serebruany, S. Steinhubl, P. Berger, A. Malinin, D. Bhatt et al., Variability in platelet responsiveness to clopidogrel among 544 individuals, Journal of the American College of Cardiology, vol.45, issue.2, pp.246-51, 2005.
DOI : 10.1016/j.jacc.2004.09.067

P. Buonamici, R. Marcucci, A. Migliorini, G. Gensini, A. Santini et al., Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis, Journal of the American College of Cardiology, vol.49, issue.24, pp.2312-2319, 2007.
DOI : 10.1016/j.jacc.2007.01.094

S. Wiviott, E. Braunwald, C. Mccabe, G. Montalescot, W. Ruzyllo et al., Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.357, issue.20, 2007.
DOI : 10.1056/NEJMoa0706482

G. Montalescot, S. Wiviott, E. Braunwald, S. Murphy, C. Gibson et al., Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial, The Lancet, vol.373, issue.9665, pp.723-754, 2009.
DOI : 10.1016/S0140-6736(09)60441-4

W. Hochholzer, S. Wiviott, E. Antman, C. Contant, J. Guo et al., Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in, Myocardial Infarction Circulation. 14 juin, vol.38123, issue.23, pp.2681-2690, 2011.

L. Wallentin, R. Becker, A. Budaj, C. Cannon, H. Emanuelsson et al., Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes, New England Journal of Medicine, vol.361, issue.11, pp.1045-57, 2009.
DOI : 10.1056/NEJMoa0904327

P. Steg, S. James, R. Harrington, D. Ardissino, R. Becker et al., Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis, Circulation, vol.122, issue.21, pp.2131-2172, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.927582

J. Chesebro, G. Knatterud, R. Roberts, J. Borer, L. Cohen et al., Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge, Circulation, vol.76, issue.1, pp.142-54, 1987.
DOI : 10.1161/01.CIR.76.1.142

M. Dewood, J. Spores, R. Notske, L. Mouser, R. Burroughs et al., Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction, New England Journal of Medicine, vol.303, issue.16, pp.897-902, 1980.
DOI : 10.1056/NEJM198010163031601

G. Stone, C. Grines, D. Cox, E. Garcia, J. Tcheng et al., Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction, New England Journal of Medicine, vol.346, issue.13, pp.957-66, 2002.
DOI : 10.1056/NEJMoa013404

C. Lee, M. Hong, J. Lee, H. Yang, J. Kim et al., Determinants and prognostic significance of spontaneous coronary recanalization in acute myocardial infarction, The American Journal of Cardiology, vol.87, issue.8, pp.951-955, 2001.
DOI : 10.1016/S0002-9149(01)01427-8

M. Hong, W. Kim, C. Park, S. Hwang, W. Kim et al., AS-63: The Predictors of Spontaneous Reperfusion in Patients with Acute ST-Elevated Myocardial Infarction, The American Journal of Cardiology, vol.103, issue.9, p.31, 2009.
DOI : 10.1016/j.amjcard.2009.01.111

D. Rimar, E. Crystal, A. Battler, S. Gottlieb, D. Freimark et al., Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction, Heart, vol.88, issue.4, pp.352-358, 2002.
DOI : 10.1136/heart.88.4.352

P. Fefer, H. Hod, H. Hammerman, V. Boyko, S. Behar et al., Relation of Clinically Defined Spontaneous Reperfusion to Outcome in ST-Elevation Myocardial Infarction, The American Journal of Cardiology, vol.103, issue.2, pp.149-53, 2009.
DOI : 10.1016/j.amjcard.2008.08.050

G. Stone, D. Cox, E. Garcia, B. Brodie, M. Morice et al., Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials, Circulation, vol.104, issue.6, pp.636-677, 2001.
DOI : 10.1161/hc3101.093701

F. Zijlstra, N. Ernst, M. De-boer, E. Nibbering, H. Suryapranata et al., Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction, Journal of the American College of Cardiology, vol.39, issue.11, pp.1733-1740, 2002.
DOI : 10.1016/S0735-1097(02)01856-9

F. Verheugt, A. Liem, F. Zijlstra, R. Marsh, G. Veen et al., High Dose Bolus Heparin as Initial Therapy Before Primary Angioplasty for Acute Myocardial Infarction: Results of the Heparin in Early Patency (HEAP) Pilot Study, Journal of the American College of Cardiology, vol.31, issue.2, pp.289-93, 1998.
DOI : 10.1016/S0735-1097(97)00495-6

C. Grines, K. Browne, J. Marco, D. Rothbaum, G. Stone et al., A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction, New England Journal of Medicine, vol.328, issue.10, pp.673-682, 1993.
DOI : 10.1056/NEJM199303113281001

R. Gibbons, D. Holmes, G. Reeder, K. Bailey, M. Hopfenspirger et al., Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction, New England Journal of Medicine, vol.328, issue.10, pp.685-91, 1993.
DOI : 10.1056/NEJM199303113281003

B. Brodie, T. Stuckey, C. Hansen, and D. Muncy, Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction, The American Journal of Cardiology, vol.85, issue.1, pp.13-21, 2000.
DOI : 10.1016/S0002-9149(99)00598-6

G. Montalescot, P. Barragan, O. Wittenberg, P. Ecollan, S. Elhadad et al., Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction, New England Journal of Medicine, vol.344, issue.25, pp.1895-903, 2001.
DOI : 10.1056/NEJM200106213442503

J. Beer, G. Dentan, L. Janin-magnificat, M. Zeller, Y. Laurent et al., Influence de l'appel au ?? 15 ?? sur les d??lais et la prise en charge des patients pr??sentant un infarctus du myocarde. Donn??es de RICO (obseRvatoire des Infarctus de C??te-d'Or), Annales de Cardiologie et d'Ang??iologie, vol.51, issue.1, pp.8-14, 2002.
DOI : 10.1016/S0003-3928(01)00057-9

J. Silvain, J. Collet, C. Nagaswami, F. Beygui, K. Edmondson et al., Composition of Coronary Thrombus in Acute Myocardial Infarction, Journal of the American College of Cardiology, vol.57, issue.12, pp.1359-67, 2011.
DOI : 10.1016/j.jacc.2010.09.077

R. Ariëns, T. Lai, J. Weisel, C. Greenberg, and P. Grant, Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms, Blood, vol.100, issue.3, pp.743-54, 2002.
DOI : 10.1182/blood.V100.3.743

G. Montalescot, D. Antoniucci, A. Kastrati, F. Neumann, M. Borentain et al., Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up, European Heart Journal, vol.28, issue.4, pp.443-452, 2007.
DOI : 10.1093/eurheartj/ehl472

G. Montalescot, M. Borentain, L. Payot, J. Collet, and D. Thomas, Early vs Late Administration of Glycoprotein IIb/IIIa Inhibitors in Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction, JAMA, vol.292, issue.3, pp.362-368, 2004.
DOI : 10.1001/jama.292.3.362

A. Van-'t-hof, T. Berg, J. Heestermans, T. Dill, T. Funck et al., Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial, The Lancet, vol.372, issue.9638, pp.537-583, 2008.
DOI : 10.1016/S0140-6736(08)61235-0

S. Ellis, M. Tendera, M. De-belder, A. Van-boven, P. Widimsky et al., Facilitated PCI in Patients with ST-Elevation Myocardial Infarction, New England Journal of Medicine, vol.358, issue.21, pp.2205-2222, 2008.
DOI : 10.1056/NEJMoa0706816

J. Mehilli, A. Kastrati, S. Schulz, S. Früngel, S. Nekolla et al., Abciximab in Patients With Acute ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading: A Randomized Double-Blind Trial, Circulation, vol.119, issue.14, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.818617

G. Montalescot, A. Hof, . Van-'t, F. Lapostolle, J. Silvain et al., Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction, New England Journal of Medicine, vol.371, issue.11, 2014.
DOI : 10.1056/NEJMoa1407024

V. Kunadian, S. James, D. Wojdyla, C. Zorkun, J. Wu et al., Angiographic Outcomes in the PLATO Trial??(Platelet Inhibition and Patient??Outcomes), JACC: Cardiovascular Interventions, vol.6, issue.7, pp.671-83, 2013.
DOI : 10.1016/j.jcin.2013.03.014

R. Dumaine, M. Borentain, O. Bertel, C. Bode, R. Gallo et al., Intravenous Low-Molecular-Weight Heparins Compared With Unfractionated Heparin in Percutaneous Coronary Intervention, Archives of Internal Medicine, vol.167, issue.22, pp.2423-2453, 2007.
DOI : 10.1001/archinte.167.22.2423

W. Klein, W. Kraxner, R. Hödl, P. Steg, A. Budaj et al., Patterns of use of heparins in ACS. Correlates and hospital outcomes: the Global Registry of Acute Coronary Events (GRACE)

G. Montalescot, S. Ellis, M. De-belder, L. Janssens, O. Katz et al., Enoxaparin in Primary and Facilitated Percutaneous Coronary Intervention, JACC: Cardiovascular Interventions, vol.3, issue.2, pp.203-215, 2010.
DOI : 10.1016/j.jcin.2009.11.012

S. Windecker, P. Kolh, F. Alfonso, J. Collet, J. Cremer et al., 2014 ESC/EACTS Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Heart J. 29 août, vol.278, 2014.

G. Montalescot, U. Zeymer, J. Silvain, B. Boulanger, M. Cohen et al., Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for STelevation myocardial infarction: the international randomised open-label ATOLL trial. The Lancet, pp.693-703, 2011.

T. Meine, M. Roe, A. Chen, M. Patel, J. Washam et al., Association of intravenous morphine use and outcomes in acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative, American Heart Journal, vol.149, issue.6, pp.1043-1052, 2005.
DOI : 10.1016/j.ahj.2005.02.010

E. Hobl, T. Stimpfl, J. Ebner, C. Schoergenhofer, U. Derhaschnig et al., Morphine Decreases Clopidogrel??Concentrations and Effects, Journal of the American College of Cardiology, vol.63, issue.7, pp.630-635, 2014.
DOI : 10.1016/j.jacc.2013.10.068

URL : http://doi.org/10.1016/j.jacc.2013.10.068

G. Parodi, R. Valenti, B. Bellandi, A. Migliorini, R. Marcucci et al., Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients, Journal of the American College of Cardiology, vol.61, issue.15, pp.1601-1607, 2013.
DOI : 10.1016/j.jacc.2013.01.024

W. Nimmo, R. Heading, J. Wilson, P. Tothill, and L. Prescott, Inhibition of gastric emptying and drug absorption by narcotic analgesics., British Journal of Clinical Pharmacology, vol.4, issue.6, pp.509-522, 1975.
DOI : 10.1111/j.1365-2125.1975.tb00568.x

M. Fernandes, R. Fish, J. Canales, J. Aliota, G. Silva et al., Restoration of microcirculatory patency after myocardial infarction: results of current coronary interventional strategies and techniques, Tex Heart Inst J Tex Heart Inst St Lukes Episcop Hosp Tex Child Hosp, vol.39, issue.3, pp.342-50, 2012.

D. Luca, G. Suryapranata, H. Zijlstra, F. Van-'t-hof, A. Hoorntje et al., Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty, ACC Current Journal Review, vol.13, issue.1, pp.991-998, 2003.
DOI : 10.1016/j.accreview.2003.10.055

R. Smalling, Ischemic Time, Journal of the American College of Cardiology, vol.54, issue.23, pp.2154-2160, 2009.
DOI : 10.1016/j.jacc.2009.08.023

D. Angiolillo, D. Schneider, D. Bhatt, W. French, M. Price et al., Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials, Journal of Thrombosis and Thrombolysis, vol.163, issue.1, pp.44-55, 2012.
DOI : 10.1007/s11239-012-0737-3

D. Bhatt, A. Lincoff, C. Gibson, G. Stone, S. Mcnulty et al., Intravenous Platelet Blockade with Cangrelor during PCI, New England Journal of Medicine, vol.361, issue.24, pp.2330-2371, 2009.
DOI : 10.1056/NEJMoa0908629

D. Bhatt, G. Stone, K. Mahaffey, C. Gibson, P. Steg et al., Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events, New England Journal of Medicine, vol.368, issue.14, pp.1303-1316, 2013.
DOI : 10.1056/NEJMoa1300815

P. Steg, D. Bhatt, C. Hamm, G. Stone, C. Gibson et al., Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data, The Lancet, vol.382, issue.9909, 2013.
DOI : 10.1016/S0140-6736(13)61615-3

P. Steg, D. Himbert, H. Benamer, G. Karrillon, A. Boccara et al., Conservative management of patients with acute myocardial infarction and spontaneous acute patency of the infarct-related artery, American Heart Journal, vol.134, issue.2, pp.248-52, 1997.
DOI : 10.1016/S0002-8703(97)70131-5

K. Bainey, Y. Fu, G. Wagner, S. Goodman, A. Ross et al., Spontaneous reperfusion in ST-elevation myocardial infarction: Comparison of angiographic and electrocardiographic assessments, American Heart Journal, vol.156, issue.2, pp.248-55, 2008.
DOI : 10.1016/j.ahj.2008.03.018

M. Roe, E. Ohman, A. Maas, R. Christenson, K. Mahaffey et al., Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion, Journal of the American College of Cardiology, vol.37, issue.1, pp.9-18, 2001.
DOI : 10.1016/S0735-1097(00)01101-3

J. De-lemos and E. Braunwald, ST segment resolution as a tool for assessing the efficacy of reperfusion therapy, Journal of the American College of Cardiology, vol.38, issue.5, pp.1283-94, 2001.
DOI : 10.1016/S0735-1097(01)01550-9

P. Sorajja, B. Gersh, C. Costantini, M. Mclaughlin, P. Zimetbaum et al., Combined Prognostic Utility of ST-Segment Recovery and Myocardial Blush After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction, ACC Current Journal Review, vol.14, issue.8, pp.667-74, 2005.
DOI : 10.1016/j.accreview.2005.08.056